Paroxetine may prevent ROS damage in diabetes patients

12/16/2012 | RedOrbit

The antidepressant paroxetine appeared to stave off reactive oxygen species molecules associated with hyperglycemia in diabetes patients, according to a study in Diabetes. Researchers said the drug prevents ROS damage by lowering concentrations and suppressing production of superoxide.

View Full Article in:

RedOrbit

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL